The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients
Journal of Breast Cancer · 2024 · 27 (3) · 163
DOI: 10.4048/jbc.2023.0248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Cancer, 2024. Verfasst von Liangqiang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Quanzhou City Science and Technology Program.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Breast Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. chenxiaosong0156@hotmail.com.
ORCID-Profile: Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Quanzhou City Science and Technology Program
Zitieren
APA
Li, L., Yu, J., Shen, K., & Chen, X. (2024). The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of Breast Cancer, 27(3), 163. https://doi.org/10.4048/jbc.2023.0248
Vancouver
Li L, Yu J, Shen K, Chen X. The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of Breast Cancer. 2024;27(3):163. doi:10.4048/jbc.2023.0248
BibTeX
@article{Li2024,
author = {Li, Liangqiang and Yu, Jing and Shen, Kunwei and Chen, Xiaosong},
title = {The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients},
journal = {Journal of Breast Cancer},
year = {2024},
volume = {27},
number = {3},
pages = {163},
doi = {10.4048/jbc.2023.0248}
}
EUVIMED